SCHEMBL6965848

SCHEMBL6965848

O=C(O)C(Sc1cccc2ccccc12)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
TDP1 Q9NUW8 2/20 0.42
CDC25B P30305 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 2/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
CTNNB1 P35222 1/20 0.39
WDR5 P61964 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7761163 0.84 NR4A1 (0.44) NR4A1NR4A2NR4A3TDP1CDC25B
SCHEMBL7373916 0.77 ALDH1A1 (0.49) CDC25BSMN1; SMN2LMNARECQLALDH1A1
SCHEMBL2831699 0.75 NR4A1 (0.50) NR4A1NR4A2NR4A3TDP1CDC25B
SCHEMBL11294594 0.75 ALDH1A1 (0.39) NR4A1NR4A2NR4A3TDP1CDC25B
SCHEMBL22500155 0.74 LMNA (0.39) NR4A1NR4A2NR4A3TDP1SMN1; SMN2
SCHEMBL6965317 0.73 ALDH1A1 (0.42) ALDH1A1SLC1A3SLC1A2SLC1A1HSD17B10
SCHEMBL9342243 0.73 CYP1A2 (0.45) TDP1SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL7761500 0.73 MMP2 (0.47) CYP1A2HDAC8MMP3
SCHEMBL8117899 0.73 HDAC8 (0.45) LMNAALDH1A1KDM4EHDAC8HDAC3
SCHEMBL7445725 0.73 HDAC3 (0.44) NR4A1NR4A2NR4A3TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed